SOX2 and cancer: Further, our immunoblotting and immunoflurescence data showed that CSC specific transcription factors, Sox-2, Oct 3/4 and Nanog were enhanced in cancer cells upon treatment with IL-6 (Additional file 1: Fig. S7 C–F).